ArticleFrontiers in pharmacology2018

Pre-treatment or Post-treatment of Human Glioma Cells With BIX01294, the Inhibitor of Histone Methyltransferase G9a, Sensitizes Cells to Temozolomide.

Iwona Anna Ciechomska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.